Rabitec

Negara: Uni Eropa

Bahasa: Inggris

Sumber: EMA (European Medicines Agency)

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
07-01-2021
Karakteristik produk Karakteristik produk (SPC)
07-01-2021

Bahan aktif:

attenuated live rabies vaccine virus, strain SPBN GASGAS

Tersedia dari:

CEVA Santé Animale

Kode ATC:

QI07BD

INN (Nama Internasional):

Rabies vaccine (live, oral) for foxes and raccoon dogs

Kelompok Terapi:

Red foxes (Vulpes vulpes); Raccoon dogs (Nyctereutes procyonoides)

Area terapi:

Immunologicals for canidae, Live viral vaccines

Indikasi Terapi:

For the active immunisation of foxes and raccoon dogs against rabies to prevent infection and mortality.

Ringkasan produk:

Revision: 3

Status otorisasi:

Authorised

Tanggal Otorisasi:

2017-12-01

Selebaran informasi

                                B. PACKAGE LEAFLET
15
PACKAGE LEAFLET
RABITEC ORAL SUSPENSION, FOR FOXES AND RACCOON DOGS
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder:
Ceva Santé Animale
10 av. de La Ballastière
33500 Libourne
France
Manufacturer responsible for batch release:
IDT Biologika GmbH
Am Pharmapark
06861 Dessau-Rosslau
Germany
Ceva Tiergesundheit (Riems) GmbH
An der Wiek 7
17493 Greifswald - Insel Riems
Germany
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rabitec oral suspension for foxes and raccoon dogs
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
1 dose (1.7 ml) embedded in bait contains:
ACTIVE SUBSTANCE:
Attenuated live rabies vaccine virus, strain SPBN GASGAS:
10
6.8
FFU* - 10
8.1
FFU*
(* Focus Forming Units)
The suspension has a yellow colour in a frozen state and a reddish
colour in the liquid state. The baits
are rectangular, brown coloured and have an intensive smell.
4.
INDICATION(S)
For the active immunization of foxes and raccoon dogs against rabies
to prevent infection and
mortality.
Duration of immunity: at least 12 months.
5.
CONTRAINDICATIONS
None.
16
6.
ADVERSE REACTIONS
Not known.
If you notice any side effects, even those not listed in this package
leaflet or you think that the
medicine has not worked, please inform your veterinary surgeon.
7.
TARGET SPECIES
Foxes, raccoon dogs
8.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
Oral use.
The intake of single bait is sufficient to ensure active immunisation
to prevent infection by rabies
virus. The baits are distributed by land or by air within the
framework of vaccination campaigns
against rabies.
The vaccination area should be as large as possible (preferably larger
than 5,000 km
2
). The vaccination
campaigns in rabies-free areas should be designed in such a way that
the area covers a 50 km belt
ahead of the rabies front. The distribution rate depends on the
topography, on the population density 
                                
                                Baca dokumen lengkapnya
                                
                            

Karakteristik produk

                                ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rabitec oral suspension for foxes and raccoon dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 dose (1.7 ml) contains:
ACTIVE SUBSTANCE:
Attenuated live rabies vaccine virus, strain SPBN GASGAS:
10
6.8
FFU* - 10
8.1
FFU*
(* Focus Forming Units)
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension.
The suspension has a yellow colour in a frozen state and a reddish
colour in the liquid state. The baits
are rectangular, brownish coloured and have an intensive smell.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Foxes, raccoon dogs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunization of foxes and raccoon dogs against rabies
to prevent infection and
mortality.
Duration of immunity: at least 12 months.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals:
Vaccine baits are not intended for vaccination of domestic animals.
Gastrointestinal signs (potentially due to the indigestible blister
material) have been reported in dogs
following accidental ingestion of the bait.
2
Special precautions to be taken by the person administering the
veterinary medicinal product to
animals:
Handle the baits with care. It is recommended to wear disposable
rubber gloves when handling and
distributing baits. In case of contact of the vaccine fluid,
immediately remove it by thoroughly rinsing
with water and soap. Seek medical advice immediately and show the
package leaflet or the label to the
physician.
Proposed first aid measures immediately after direct human exposure to
the vaccine fluid should
follow the recommendations of the WHO as outlined in the “WHO Guide
for Rabies Pre- and Post-
Exposure Prophylaxis (PEP) in Humans”.
Since this vaccine has been prepared with live, attenuated
microorganisms, appropriate measures
should be taken to prevent contamination of the handler a
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Bulgar 07-01-2021
Karakteristik produk Karakteristik produk Bulgar 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Bulgar 03-04-2020
Selebaran informasi Selebaran informasi Spanyol 07-01-2021
Karakteristik produk Karakteristik produk Spanyol 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Spanyol 03-04-2020
Selebaran informasi Selebaran informasi Cheska 07-01-2021
Karakteristik produk Karakteristik produk Cheska 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Cheska 03-04-2020
Selebaran informasi Selebaran informasi Dansk 07-01-2021
Karakteristik produk Karakteristik produk Dansk 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Dansk 03-04-2020
Selebaran informasi Selebaran informasi Jerman 07-01-2021
Karakteristik produk Karakteristik produk Jerman 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Jerman 03-04-2020
Selebaran informasi Selebaran informasi Esti 07-01-2021
Karakteristik produk Karakteristik produk Esti 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Esti 03-04-2020
Selebaran informasi Selebaran informasi Yunani 07-01-2021
Karakteristik produk Karakteristik produk Yunani 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Yunani 03-04-2020
Selebaran informasi Selebaran informasi Prancis 07-01-2021
Karakteristik produk Karakteristik produk Prancis 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Prancis 03-04-2020
Selebaran informasi Selebaran informasi Italia 07-01-2021
Karakteristik produk Karakteristik produk Italia 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Italia 03-04-2020
Selebaran informasi Selebaran informasi Latvi 07-01-2021
Karakteristik produk Karakteristik produk Latvi 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Latvi 03-04-2020
Selebaran informasi Selebaran informasi Lituavi 07-01-2021
Karakteristik produk Karakteristik produk Lituavi 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Lituavi 03-04-2020
Selebaran informasi Selebaran informasi Hungaria 07-01-2021
Karakteristik produk Karakteristik produk Hungaria 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Hungaria 03-04-2020
Selebaran informasi Selebaran informasi Malta 07-01-2021
Karakteristik produk Karakteristik produk Malta 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Malta 03-04-2020
Selebaran informasi Selebaran informasi Belanda 07-01-2021
Karakteristik produk Karakteristik produk Belanda 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Belanda 03-04-2020
Selebaran informasi Selebaran informasi Polski 07-01-2021
Karakteristik produk Karakteristik produk Polski 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Polski 03-04-2020
Selebaran informasi Selebaran informasi Portugis 07-01-2021
Karakteristik produk Karakteristik produk Portugis 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Portugis 03-04-2020
Selebaran informasi Selebaran informasi Rumania 07-01-2021
Karakteristik produk Karakteristik produk Rumania 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Rumania 03-04-2020
Selebaran informasi Selebaran informasi Slovak 07-01-2021
Karakteristik produk Karakteristik produk Slovak 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Slovak 03-04-2020
Selebaran informasi Selebaran informasi Sloven 07-01-2021
Karakteristik produk Karakteristik produk Sloven 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Sloven 03-04-2020
Selebaran informasi Selebaran informasi Suomi 07-01-2021
Karakteristik produk Karakteristik produk Suomi 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Suomi 03-04-2020
Selebaran informasi Selebaran informasi Swedia 07-01-2021
Karakteristik produk Karakteristik produk Swedia 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Swedia 03-04-2020
Selebaran informasi Selebaran informasi Norwegia 07-01-2021
Karakteristik produk Karakteristik produk Norwegia 07-01-2021
Selebaran informasi Selebaran informasi Islandia 07-01-2021
Karakteristik produk Karakteristik produk Islandia 07-01-2021
Selebaran informasi Selebaran informasi Kroasia 07-01-2021
Karakteristik produk Karakteristik produk Kroasia 07-01-2021
Laporan Penilaian publik Laporan Penilaian publik Kroasia 03-04-2020

Lihat riwayat dokumen